Laurus Labs shares hit a record high after Q2FY27 revenue rose 33% and net profit jumped 126%. The company declared an interim dividend and expanded peptide manufacturing. While brokerages recognized growth prospects, they urged investors to weigh potential against the stock’s sharp rally.
Laurus Labs shares hit a record high after Q2FY27 revenue rose 33% and net profit jumped 126%. The company declared an interim dividend and expanded peptide manufacturing. While brokerages recognized growth prospects, they urged investors to weigh potential against the stock’s sharp rally.
<iframe src="https://hindustansphere.com/embed/cluster/2a9b72898cbeb82520ee19533eaec44ea54ff591" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Laurus Labs share price at record high after Q2 results 2026, dividend announcement - Should you buy pharma stock?"></iframe>
